# US 8,278,104 B2 · Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,104 B2
- Document ID: US8278104B2
- Status: Granted
- Kind: B2
- Application number: 12/213,035
- Filed: 2008-06-13
- Published: 2009-02-19
- Granted: 2012-10-02
- Earliest claimed: 2005-12-13
- Assignees: Kyoto University
- Inventors: Shinya Yamanaka; Kazutoshi Takahashi; Keisuke Okita
- Web page: https://patentgrep.com/patent/US8278104B2

## CPC

- C07K 14/4702: {Regulators; Modulating activity}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- C12N 2501/60: Transcription factors
- C12N 2501/602: Sox-2
- C12N 2501/603: Oct-3/4
- C12N 2501/604: Klf-4
- C12N 2510/00: Genetically modified cells
- C12N 2740/15043: viral genome or elements thereof as genetic vector
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a nuclear reprogramming factor having an action of reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell. The present invention also relates to the aforementioned iPS cells, methods of generating and maintaining iPS cells, and methods of using iPS cells, including screening and testing methods as well as methods of stem cell therapy. The present invention also relates to somatic cells derived by inducing differentiation of the aforementioned iPS cells.

## Claims

### Claim 1

A method for preparing an induced pluripotent stem cell by nuclear reprogramming of a mammalian somatic cell, comprising:
a) introducing into the mammalian somatic cell one or more retroviral vectors comprising Oct3/4, Klf4 and Sox2 operably linked to a promoter, and
b) culturing the transduced somatic cell in the presence of a cytokine on a fibroblast feeder layer or extracellular matrix under conditions that maintain pluripotency and self renewal.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the mammalian somatic cell is a human cell.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the mammalian somatic cell is a mouse cell.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the cytokine is bFGF and/or SCF.
